Pediatrix Medical Group MD Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Pediatrix Medical Group in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pediatrix Medical Group's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pediatrix Medical Group's stock-based comp?
- Pediatrix Medical Group (MD) reported stock-based comp of $4.66M in Q1 2026.
- How has Pediatrix Medical Group's stock-based comp changed year-over-year?
- Pediatrix Medical Group's stock-based comp increased by 28.0% year-over-year, from $3.64M to $4.66M.
- What is the long-term trend for Pediatrix Medical Group's stock-based comp?
- Over 4 years (2021 to 2025), Pediatrix Medical Group's stock-based comp has grown at a -1.2% compound annual growth rate (CAGR), from $18.97M to $18.05M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.